{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T16:54:19Z","timestamp":1772470459017,"version":"3.50.1"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,9,22]],"date-time":"2021-09-22T00:00:00Z","timestamp":1632268800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,9,22]],"date-time":"2021-09-22T00:00:00Z","timestamp":1632268800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Heroin use continues to drive HIV transmission in Vietnam, but methamphetamine and alcohol use are growing rapidly and, as in other countries, polysubstance use is widespread. The objective of this study was to understand the interplay between heroin, methamphetamine, and alcohol use among people with opioid use disorder (OUD) and HIV in Vietnam.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We conducted 44 in-depth, face-to-face qualitative interviews with people with OUD and HIV who participated in the BRAVO trial of buprenorphine versus methadone in five Vietnam HIV clinics. Interviews probed participants\u2019 experiences of heroin, methamphetamine, and alcohol use and their interplay with HIV\/OUD treatment. Interviews were professionally transcribed and analyzed using a thematic analysis approach.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Of 44 participants interviewed 42 were male, on average 38.8\u2009years of age, with 30 reporting a history of methamphetamine use and 33 reporting a history of alcohol use. Several themes emerged: 1) Methamphetamine and alcohol were perceived to have lower addiction potential than heroin 2) Social settings were key facilitators of alcohol and methamphetamine use 3) Some participants, but not all, used methamphetamine to help quit heroin 4) Consuming alcohol blunted the effects of heroin, while paradoxically serving as a catalyst for heroin use 5) Use of methamphetamine was perceived by many participants to be incompatible with treatment for HIV.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Participant experiences reflected a significant impact of polysubstance use on treatment of HIV and OUD. Patterns of polysubstance use are subject to common preconceptions of alcohol and methamphetamine as having a low addictive potential, and these substances are deeply enmeshed in the social life of many people with OUD in Vietnam. Interventions to address complex social norms and potential harms of polysubstance use are urgently needed as the population of people receiving medication for OUD (MOUD) increases in Vietnam and globally.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Trial registration<\/jats:title>\n                <jats:p>BRAVO - <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/clinicaltrials.gov\/ct2\/show\/study\/NCT01936857\">NCT01936857<\/jats:ext-link>, September 2013.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12889-021-11783-9","type":"journal-article","created":{"date-parts":[[2021,9,22]],"date-time":"2021-09-22T00:02:24Z","timestamp":1632268944000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Use of methamphetamine and alcohol among people with opioid use disorder and HIV in Vietnam: a qualitative study"],"prefix":"10.1186","volume":"21","author":[{"given":"Andrew","family":"Edsall","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kim A.","family":"Hoffman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dinh Thanh","family":"Thuy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pham Phuong","family":"Mai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nguyen Thu","family":"Hang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tong Thi","family":"Khuyen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nguyen Thu","family":"Trang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lynn E.","family":"Kunkel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Le Minh","family":"Giang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P. Todd","family":"Korthuis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,9,22]]},"reference":[{"key":"11783_CR1","volume-title":"World Drug Report 2020","author":"UNODC","year":"2020","unstructured":"UNODC. Booklet 2: Drug Use and Health Consequences. In: World Drug Report 2020; 2020."},{"issue":"12","key":"11783_CR2","doi-asserted-by":"publisher","first-page":"e1192","DOI":"10.1016\/S2214-109X(17)30375-3","volume":"5","author":"L Degenhardt","year":"2017","unstructured":"Degenhardt L, Peacock A, Colledge S, Leung J, Grebely J, Vickerman P, et al. Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: a multistage systematic review. Lancet Glob Health. 2017;5(12):e1192\u2013207. https:\/\/doi.org\/10.1016\/S2214-109X(17)30375-3.","journal-title":"Lancet Glob Health"},{"key":"11783_CR3","volume-title":"2020 Global AIDS Report","author":"UNAIDS","year":"2020","unstructured":"UNAIDS. 2020 Global AIDS Report. 2020."},{"key":"11783_CR4","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.drugalcdep.2019.01.031","volume":"198","author":"AN Hassan","year":"2019","unstructured":"Hassan AN, Le Foll B. Polydrug use disorders in individuals with opioid use disorder. Drug Alcohol Depend. 2019;198:28\u201333. https:\/\/doi.org\/10.1016\/j.drugalcdep.2019.01.031.","journal-title":"Drug Alcohol Depend"},{"key":"11783_CR5","first-page":"29","volume-title":"Polydrug use: patterns and responses","author":"European Commission","year":"2009","unstructured":"European Commission. Polydrug use: patterns and responses. Luxembourg: Publ. Off. of the Europ. Union; 2009. p. 29. (Selected issue \/ European Monitoring Centre for Drugs and Drug Addiction)"},{"issue":"2","key":"11783_CR6","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1080\/13651501.2017.1383439","volume":"22","author":"M Yang","year":"2018","unstructured":"Yang M, Huang S-C, Liao Y-H, Deng Y-M, Run H-Y, Liu P-L, et al. Clinical characteristics of poly-drug abuse among heroin dependents and association with other psychopathology in compulsory isolation treatment settings in China. Int J Psychiatry Clin Pract. 2018;22(2):129\u201335. https:\/\/doi.org\/10.1080\/13651501.2017.1383439.","journal-title":"Int J Psychiatry Clin Pract"},{"issue":"8","key":"11783_CR7","doi-asserted-by":"publisher","first-page":"e55","DOI":"10.2105\/AJPH.2015.302664","volume":"105","author":"CM Jones","year":"2015","unstructured":"Jones CM, Campopiano M, Baldwin G, McCance-Katz E. National and state treatment need and capacity for opioid agonist medication-assisted treatment. Am J Public Health. 2015;105(8):e55\u201363. https:\/\/doi.org\/10.2105\/AJPH.2015.302664.","journal-title":"Am J Public Health"},{"issue":"2","key":"11783_CR8","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1159\/000363232","volume":"21","author":"M Soyka","year":"2015","unstructured":"Soyka M. Alcohol use disorders in opioid maintenance therapy: prevalence, clinical correlates and treatment. Eur Addict Res. 2015;21(2):78\u201387. https:\/\/doi.org\/10.1159\/000363232.","journal-title":"Eur Addict Res"},{"issue":"1","key":"11783_CR9","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s13722-016-0065-6","volume":"11","author":"S Nolan","year":"2016","unstructured":"Nolan S, Klimas J, Wood E. Alcohol use in opioid agonist treatment. Addict Sci Clin Pract. 2016;11(1):17. https:\/\/doi.org\/10.1186\/s13722-016-0065-6.","journal-title":"Addict Sci Clin Pract"},{"key":"11783_CR10","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.drugalcdep.2018.08.029","volume":"193","author":"MS Ellis","year":"2018","unstructured":"Ellis MS, Kasper ZA, Cicero TJ. Twin epidemics: the surging rise of methamphetamine use in chronic opioid users. Drug Alcohol Depend. 2018;193:14\u201320. https:\/\/doi.org\/10.1016\/j.drugalcdep.2018.08.029.","journal-title":"Drug Alcohol Depend"},{"issue":"8","key":"11783_CR11","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1080\/10826084.2016.1271432","volume":"52","author":"A Al-Tayyib","year":"2017","unstructured":"Al-Tayyib A, Koester S, Langegger S, Raville L. Heroin and methamphetamine injection: an emerging drug use pattern. Subst Use Misuse. 2017;52(8):1051\u20138. https:\/\/doi.org\/10.1080\/10826084.2016.1271432.","journal-title":"Subst Use Misuse."},{"key":"11783_CR12","doi-asserted-by":"publisher","DOI":"10.18356\/a4dd519a-en","volume-title":"World drug report 2019 (set of 5 booklets). S.l.: united nations","author":"United Nations Office on Drugs and Crime","year":"2019","unstructured":"United Nations Office on Drugs and Crime. World drug report 2019 (set of 5 booklets). S.l.: united nations; 2019."},{"issue":"2","key":"11783_CR13","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1111\/add.14451","volume":"114","author":"T Chen","year":"2019","unstructured":"Chen T, Zhong N, Du J, Li Z, Zhao Y, Sun H, et al. Polydrug use patterns and their impact on relapse among heroin-dependent patients in Shanghai, China. Addiction. 2019;114(2):259\u201367. https:\/\/doi.org\/10.1111\/add.14451.","journal-title":"Addiction"},{"key":"11783_CR14","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.drugpo.2017.07.009","volume":"49","author":"L Wang","year":"2017","unstructured":"Wang L, Min JE, Krebs E, Evans E, Huang D, Liu L, et al. Polydrug use and its association with drug treatment outcomes among primary heroin, methamphetamine, and cocaine users. Int J Drug Policy. 2017;49:32\u201340. https:\/\/doi.org\/10.1016\/j.drugpo.2017.07.009.","journal-title":"Int J Drug Policy."},{"key":"11783_CR15","doi-asserted-by":"publisher","unstructured":"Ford BR, Bart G, Grahan B, Shearer RD, Winkelman TNA. Associations Between Polysubstance Use Patterns and Receipt of Medications for Opioid Use Disorder Among Adults in Treatment for Opioid Use Disorder. J Addict Med. 2021;15(2):159\u201362. https:\/\/doi.org\/10.1097\/ADM.0000000000000726.","DOI":"10.1097\/ADM.0000000000000726"},{"issue":"1","key":"11783_CR16","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1111\/j.1521-0391.2013.12074.x","volume":"23","author":"M Ferri","year":"2014","unstructured":"Ferri M, Finlayson AJR, Wang L, Martin PR. Predictive factors for relapse in patients on buprenorphine maintenance: relapse factors in buprenorphine maintenance. Am J Addict. 2014;23(1):62\u20137. https:\/\/doi.org\/10.1111\/j.1521-0391.2013.12074.x.","journal-title":"Am J Addict"},{"issue":"9739","key":"11783_CR17","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1016\/S0140-6736(10)60753-2","volume":"376","author":"G Colfax","year":"2010","unstructured":"Colfax G, Santos G-M, Chu P, Vittinghoff E, Pluddemann A, Kumar S, et al. Amphetamine-group substances and HIV. Lancet. 2010;376(9739):458\u201374. https:\/\/doi.org\/10.1016\/S0140-6736(10)60753-2.","journal-title":"Lancet"},{"issue":"6","key":"11783_CR18","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1086\/381975","volume":"38","author":"A Urbina","year":"2004","unstructured":"Urbina A, Jones K. Crystal methamphetamine, its analogues, and HIV infection: medical and psychiatric aspects of a new epidemic. Clin Infect Dis. 2004;38(6):890\u20134. https:\/\/doi.org\/10.1086\/381975.","journal-title":"Clin Infect Dis"},{"key":"11783_CR19","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.drugalcdep.2015.12.027","volume":"159","author":"J Jiang","year":"2016","unstructured":"Jiang J, Wang M, Liang B, Shi Y, Su Q, Chen H, et al. In vivo effects of methamphetamine on HIV-1 replication: a population-based study. Drug Alcohol Depend. 2016;159:246\u201354. https:\/\/doi.org\/10.1016\/j.drugalcdep.2015.12.027.","journal-title":"Drug Alcohol Depend"},{"issue":"5","key":"11783_CR20","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1097\/00126334-200312150-00004","volume":"34","author":"D Langford","year":"2003","unstructured":"Langford D, Adame A, Grigorian A, Grant I, McCutchan JA, Ellis RJ, et al. Patterns of Selective Neuronal Damage in Methamphetamine-User AIDS Patients. JAIDS J Acquir Immune Defic Syndr. 2003;34(5):467\u201374. https:\/\/doi.org\/10.1097\/00126334-200312150-00004.","journal-title":"JAIDS J Acquir Immune Defic Syndr"},{"issue":"2","key":"11783_CR21","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1097\/QAD.0b013e3280114a29","volume":"21","author":"GN Colfax","year":"2007","unstructured":"Colfax GN, Vittinghoff E, Grant R, Lum P, Spotts G, Hecht FM. Frequent methamphetamine us is associated with primary non-nucleoside reverse transcriptase inhibitor resistance. AIDS. 2007;21(2):237\u20139. https:\/\/doi.org\/10.1097\/QAD.0b013e3280114a29.","journal-title":"AIDS."},{"issue":"12","key":"11783_CR22","doi-asserted-by":"publisher","first-page":"1820","DOI":"10.1086\/379894","volume":"188","author":"RJ Ellis","year":"2003","unstructured":"Ellis RJ, Childers ME, Cherner M, Lazzaretto D, Letendre S, Grant I, et al. Increased human immunodeficiency virus loads in active methamphetamine users are explained by reduced effectiveness of antiretroviral therapy. J Infect Dis. 2003;188(12):1820\u20136. https:\/\/doi.org\/10.1086\/379894.","journal-title":"J Infect Dis"},{"issue":"S1","key":"11783_CR23","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s10461-010-9725-9","volume":"14","author":"MB Nayak","year":"2010","unstructured":"Nayak MB, Korcha RA, Benegal V. Alcohol use, mental health, and HIV-related risk behaviors among adult men in Karnataka. AIDS Behav. 2010;14(S1):61\u201373. https:\/\/doi.org\/10.1007\/s10461-010-9725-9.","journal-title":"AIDS Behav"},{"issue":"1\u20133","key":"11783_CR24","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.drugalcdep.2012.06.024","volume":"127","author":"C Le Marchand","year":"2013","unstructured":"Le Marchand C, Evans J, Page K, Davidson PJ, Hahn JA. Hazardous alcohol consumption among young adult IDU and its association with high risk behaviors. Drug Alcohol Depend. 2013;127(1\u20133):143\u20139. https:\/\/doi.org\/10.1016\/j.drugalcdep.2012.06.024.","journal-title":"Drug Alcohol Depend"},{"issue":"4","key":"11783_CR25","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1007\/s11904-010-0060-6","volume":"7","author":"JA Hahn","year":"2010","unstructured":"Hahn JA, Samet JH. Alcohol and HIV disease progression: weighing the evidence. Curr HIV\/AIDS Rep. 2010;7(4):226\u201333. https:\/\/doi.org\/10.1007\/s11904-010-0060-6.","journal-title":"Curr HIV\/AIDS Rep"},{"issue":"5","key":"11783_CR26","doi-asserted-by":"publisher","first-page":"e129","DOI":"10.1097\/QAI.0b013e31820dc1c8","volume":"56","author":"ES Wu","year":"2011","unstructured":"Wu ES, Metzger DS, Lynch KG, Douglas SD. Association Between Alcohol Use and HIV Viral Load. JAIDS J Acquir Immune Defic Syndr. 2011;56(5):e129\u201330. https:\/\/doi.org\/10.1097\/QAI.0b013e31820dc1c8.","journal-title":"JAIDS J Acquir Immune Defic Syndr"},{"issue":"3","key":"11783_CR27","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1111\/acer.12282","volume":"38","author":"PS Silverstein","year":"2014","unstructured":"Silverstein PS, Kumar A. HIV-1 and alcohol: interactions in the central nervous system. Alcohol Clin Exp Res. 2014;38(3):604\u201310. https:\/\/doi.org\/10.1111\/acer.12282.","journal-title":"Alcohol Clin Exp Res"},{"issue":"7","key":"11783_CR28","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1046\/j.1360-0443.1999.9479612.x","volume":"94","author":"JM White","year":"1999","unstructured":"White JM, Irvine RJ. Mechanisms of fatal opioid overdose. Addiction. 1999;94(7):961\u201372. https:\/\/doi.org\/10.1046\/j.1360-0443.1999.9479612.x.","journal-title":"Addiction."},{"issue":"1","key":"11783_CR29","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1046\/j.1360-0443.2003.00236.x","volume":"98","author":"F Leri","year":"2003","unstructured":"Leri F, Bruneau J, Stewart J. Understanding polydrug use: review of heroin and cocaine co-use. Addiction. 2003;98(1):7\u201322. https:\/\/doi.org\/10.1046\/j.1360-0443.2003.00236.x.","journal-title":"Addiction."},{"key":"11783_CR30","doi-asserted-by":"crossref","unstructured":"Baker R, Leichtling G, Hildebran C, Pinela C, Waddell EN, Sidlow C, et al. \u201cLike Yin and Yang\u201d: Perceptions of Methamphetamine Benefits and Consequences Among People Who Use Opioids in Rural Communities. J Addict Med. 2020; [cited 2020 Oct 27];Publish Ahead of Print. Available from: https:\/\/journals.lww.com\/journaladdictionmedicine\/Abstract\/9000\/_Like_Yin_and_Yang___Perceptions_of.99214.aspx.","DOI":"10.1097\/ADM.0000000000000669"},{"issue":"1","key":"11783_CR31","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s12954-020-00360-9","volume":"17","author":"A Palmer","year":"2020","unstructured":"Palmer A, Scott N, Dietze P, Higgs P. Motivations for crystal methamphetamine-opioid co-injection\/co-use amongst community-recruited people who inject drugs: a qualitative study. Harm Reduct J. 2020;17(1):14. https:\/\/doi.org\/10.1186\/s12954-020-00360-9.","journal-title":"Harm Reduct J"},{"issue":"3","key":"11783_CR32","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1111\/dar.13049","volume":"39","author":"R McNeil","year":"2020","unstructured":"McNeil R, Puri N, Boyd J, Mayer S, Hayashi K, Small W. Understanding concurrent stimulant use among people on methadone: a qualitative study. Drug Alcohol Rev. 2020;39(3):209\u201315. https:\/\/doi.org\/10.1111\/dar.13049.","journal-title":"Drug Alcohol Rev"},{"key":"11783_CR33","unstructured":"AIDSinfo | UNAIDS [Internet]. [cited 2020 Oct 28]. Available from: https:\/\/aidsinfo.unaids.org\/"},{"key":"11783_CR34","doi-asserted-by":"publisher","unstructured":"Nong T, Capoccia V, Mulvey KP. Facing the future of substance use disorders treatment in Vietnam \u2013 a case study for international development and cooperation. J Subst Abus Treat. 2021:108401. https:\/\/doi.org\/10.1016\/j.jsat.2021.108401.","DOI":"10.1016\/j.jsat.2021.108401"},{"key":"11783_CR35","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.drugpo.2018.02.020","volume":"55","author":"T Hoang","year":"2018","unstructured":"Hoang T, Nguyen H, Shiraishi RW, Nguyen M, Bingham T, Nguyen D, et al. Factors associated with concurrent heroin use among patients on methadone maintenance treatment in Vietnam: a 24-month retrospective analysis of a nationally representative sample. Int J Drug Policy. 2018;55:113\u201320. https:\/\/doi.org\/10.1016\/j.drugpo.2018.02.020.","journal-title":"Int J Drug Policy."},{"issue":"2","key":"11783_CR36","doi-asserted-by":"publisher","first-page":"e55750","DOI":"10.1371\/journal.pone.0055750","volume":"8","author":"DB Nguyen","year":"2013","unstructured":"Nguyen DB, Do NT, Shiraishi RW, Le YN, Tran QH, Huu Nguyen H, et al. Outcomes of Antiretroviral Therapy in Vietnam: Results from a National Evaluation. PLoS ONE. 2013;8(2):e55750.","journal-title":"PLoS ONE"},{"issue":"18","key":"11783_CR37","doi-asserted-by":"publisher","first-page":"3277","DOI":"10.3390\/ijerph16183277","volume":"16","author":"TA Le","year":"2019","unstructured":"Le TA, Pham DTT, Quek TTC, Vu GT, Hoang CL, Tran TT, et al. Polysubstance use among patients enrolling in methadone maintenance treatment program in a Vietnam Province with drug-driven HIV epidemic. Int J Environ Res Public Health. 2019;16(18):3277. https:\/\/doi.org\/10.3390\/ijerph16183277.","journal-title":"Int J Environ Res Public Health"},{"key":"11783_CR38","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.drugalcdep.2017.07.004","volume":"179","author":"L Michel","year":"2017","unstructured":"Michel L, Des Jarlais DC, Duong Thi H, Khuat Thi Hai O, Pham Minh K, Peries M, et al. Intravenous heroin use in Haiphong, Vietnam: need for comprehensive care including methamphetamine use-related interventions. Drug Alcohol Depend. 2017;179:198\u2013204. https:\/\/doi.org\/10.1016\/j.drugalcdep.2017.07.004.","journal-title":"Drug Alcohol Depend"},{"issue":"5","key":"11783_CR39","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1080\/02791072.2018.1508790","volume":"50","author":"J Feelemyer","year":"2018","unstructured":"Feelemyer J, Duong Thi H, Khu\u00ea Pham M, Hoang Thi G, Thi Tuyet Thanh N, Thi Hai Oanh K, et al. Increased methamphetamine use among persons who inject drugs in Hai Phong, Vietnam, and the association with injection and sexual risk behaviors. J Psychoactive Drugs. 2018;50(5):382\u20139. https:\/\/doi.org\/10.1080\/02791072.2018.1508790.","journal-title":"J Psychoactive Drugs"},{"issue":"4","key":"11783_CR40","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.drugpo.2012.12.003","volume":"24","author":"VF Go","year":"2013","unstructured":"Go VF, Minh NL, Frangakis C, Ha TV, Latkin CA, Sripaipan T, et al. Decreased injecting is associated with increased alcohol consumption among injecting drug users in northern Vietnam. Int J Drug Policy. 2013;24(4):304\u201311. https:\/\/doi.org\/10.1016\/j.drugpo.2012.12.003.","journal-title":"Int J Drug Policy."},{"issue":"4","key":"11783_CR41","doi-asserted-by":"publisher","first-page":"S42","DOI":"10.1016\/j.jfda.2013.09.032","volume":"21","author":"LM Giang","year":"2013","unstructured":"Giang LM, Ngoc LB, Hoang VH, Mulvey K, Rawson RA. Substance use disorders and HIV in Vietnam since Doi Moi (renovation): an overview. J Food Drug Anal. 2013;21(4):S42\u20135. https:\/\/doi.org\/10.1016\/j.jfda.2013.09.032.","journal-title":"J Food Drug Anal"},{"key":"11783_CR42","unstructured":"United Nations Office on Drugs and Crime. Synthetic Drugs in East and Southeast Asia.\u00a0Bangkok: United Nations; 2019."},{"key":"11783_CR43","doi-asserted-by":"publisher","first-page":"S67","DOI":"10.1097\/PHH.0000000000000733","volume":"24","author":"CV Pham","year":"2018","unstructured":"Pham CV, Tran HTD, Tran NT. Alcohol consumption and binge drinking among adult population: evidence from the CHILILAB health and demographic surveillance system in Vietnam. J Public Health Manag Pract. 2018;24:S67\u201373. https:\/\/doi.org\/10.1097\/PHH.0000000000000733.","journal-title":"J Public Health Manag Pract"},{"issue":"1","key":"11783_CR44","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s12954-016-0096-z","volume":"13","author":"BX Tran","year":"2016","unstructured":"Tran BX, Nguyen LH, Nguyen CT, Phan HTT, Latkin CA. Alcohol abuse increases the risk of HIV infection and diminishes health status of clients attending HIV testing services in Vietnam. Harm Reduct J. 2016;13(1):6. https:\/\/doi.org\/10.1186\/s12954-016-0096-z.","journal-title":"Harm Reduct J"},{"key":"11783_CR45","doi-asserted-by":"publisher","unstructured":"Polenick CA, Cotton BP, Bryson WC, Birditt KS. Loneliness and illicit opioid use among methadone maintenance treatment patients. Subst Use Misuse. 2019;(13):1\u201310. https:\/\/doi.org\/10.1080\/10826084.2019.1628276.","DOI":"10.1080\/10826084.2019.1628276"},{"key":"11783_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.drugalcdep.2015.10.030","volume":"159","author":"M Lincoln","year":"2016","unstructured":"Lincoln M. Alcohol and drinking cultures in Vietnam: a review. Drug Alcohol Depend. 2016;159:1\u20138. https:\/\/doi.org\/10.1016\/j.drugalcdep.2015.10.030.","journal-title":"Drug Alcohol Depend"},{"key":"11783_CR47","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.drugpo.2018.08.017","volume":"62","author":"L Liu","year":"2018","unstructured":"Liu L, Chui WH, Chai X. A qualitative study of methamphetamine initiation among Chinese male users: patterns and policy implications. Int J Drug Policy. 2018;62:37\u201342. https:\/\/doi.org\/10.1016\/j.drugpo.2018.08.017.","journal-title":"Int J Drug Policy"},{"key":"11783_CR48","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.neuroscience.2016.01.043","volume":"322","author":"T Mori","year":"2016","unstructured":"Mori T, Iwase Y, Saeki T, Iwata N, Murata A, Masukawa D, et al. Differential activation of dopaminergic systems in rat brain basal ganglia by morphine and methamphetamine. Neuroscience. 2016;322:164\u201370. https:\/\/doi.org\/10.1016\/j.neuroscience.2016.01.043.","journal-title":"Neuroscience."},{"key":"11783_CR49","doi-asserted-by":"publisher","unstructured":"Sun Y, Chang S, Liu Z, Zhang L, Wang F, Yue W, et al. Identification of novel risk loci with shared effects on alcoholism, heroin, and methamphetamine dependence. Mol Psychiatry. 2019. https:\/\/doi.org\/10.2139\/ssrn.3323117.","DOI":"10.2139\/ssrn.3323117"}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-021-11783-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12889-021-11783-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-021-11783-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,22]],"date-time":"2021-09-22T00:02:40Z","timestamp":1632268960000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpublichealth.biomedcentral.com\/articles\/10.1186\/s12889-021-11783-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,22]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["11783"],"URL":"https:\/\/doi.org\/10.1186\/s12889-021-11783-9","relation":{},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,22]]},"assertion":[{"value":"25 April 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Institutional review boards at Oregon Health & Science University (IRB00000471) and Hanoi Medical University (IRB00003121) approved the study, and all research activities have been performed in accordance with the Declaration of Helsinki. All participants completed written informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1718"}}